2025
SJR Q2
JCR Q3 · 1,6
211 matched articles
SCIE
Journal detail
Annals of Vascular Surgery
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0890509616155947
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,668
- Quartile Q2
- H-Index 90
- Cites/doc 1,82
- Docs (3y) 1.422
- Cites (3y) 2.572
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,6
- 5Y JIF 1,5
- JCI 0,56
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q2
- Medicine (miscellaneous) Q2
- Surgery Q2
Areas
- Medicine
WoS categories
- Surgery | Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,668 | 1,6 | 1,5 | 0,56 | Q3 | 90 |
| 2024 | Q2 | Q3 | 0,707 | 1,6 | 1,5 | 0,57 | Q3 | 87 |
| 2023 | Q2 | Q3 | 0,616 | 1,4 | 1,4 | 0,53 | Q2 | 87 |
| 2022 | Q2 | Q3 | 0,65 | 1,5 | 1,5 | 0,51 | Q3 | 87 |
| 2021 | Q2 | Q4 | 0,511 | 1,6 | 1,6 | 0,45 | Q3 | 87 |
| 2020 | Q2 | Q4 | 0,635 | 1,5 | 1,5 | 0,4 | Q3 | 87 |
| 2019 | Q2 | Q4 | 0,598 | 1,1 | 1,2 | 0,41 | Q3 | 87 |
| 2018 | — | Q3 | — | 1,2 | 1,2 | 0,4 | Q3 | — |
| 2017 | Q2 | Q3 | 0,653 | 1,4 | 1,4 | 0,4 | Q3 | 87 |
| 2016 | Q2 | Q3 | 0,611 | 1,1 | 1,2 | — | — | 87 |
| 2015 | Q2 | Q3 | 0,606 | 1 | 1,1 | — | — | 87 |
| 2014 | Q2 | Q3 | 0,655 | 1,2 | 1,1 | — | — | 87 |
| 2013 | Q2 | Q3 | 0,657 | 1 | 1,1 | — | — | 87 |
| 2012 | Q2 | Q3 | 0,608 | 1 | 1,1 | — | — | 87 |
| 2011 | Q2 | Q3 | 0,739 | 1 | 1,2 | — | — | 87 |
| 2010 | Q2 | Q2 | 0,679 | 1,3 | 1,4 | — | — | 87 |
| 2009 | — | Q3 | — | 1,2 | 1,6 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1,8 | — | — | — |
| 2007 | — | Q2 | — | 1,5 | 1,6 | — | — | — |
| 2006 | — | Q2 | — | 1,2 | — | — | — | — |
| 2005 | — | Q2 | — | 1,2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,1 | — | — | — | — |
| 2003 | — | Q3 | — | 0,9 | — | — | — | — |
| 2002 | — | Q2 | — | 0,9 | — | — | — | — |
| 2001 | — | Q2 | — | 1,1 | — | — | — | — |
| 2000 | — | Q2 | — | 1,1 | — | — | — | — |
| 1999 | — | Q2 | — | 1,1 | — | — | — | — |
| 1998 | — | Q2 | — | 0,9 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 73/100 |
| 2025 | SURGERY | SCIE | Q3 | Q3 | 176/321 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 70/98 |
| 2024 | SURGERY | SCIE | Q3 | Q3 | 158/314 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 72/96 |
| 2023 | SURGERY | SCIE | Q3 | Q3 | 166/292 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/68 |
| 2022 | SURGERY | SCIE | Q3 | Q3 | 154/213 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/67 |
| 2021 | SURGERY | SCIE | Q4 | Q3 | 162/213 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 60/65 |
| 2020 | SURGERY | SCIE | Q4 | Q3 | 170/211 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 62/65 |
| 2019 | SURGERY | SCIE | Q4 | Q3 | 166/210 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/65 |
| 2018 | SURGERY | SCIE | Q3 | Q3 | 151/203 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 53/65 |
| 2017 | SURGERY | SCIE | Q3 | Q3 | 129/200 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/63 |
| 2016 | SURGERY | SCIE | Q3 | — | 140/197 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 58/63 |
| 2015 | SURGERY | SCIE | Q3 | — | 136/200 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 54/60 |
| 2014 | SURGERY | SCIE | Q3 | — | 121/198 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/65 |
| 2013 | SURGERY | SCIE | Q3 | — | 141/204 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 55/68 |
| 2012 | SURGERY | SCIE | Q3 | — | 128/199 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/68 |
| 2011 | SURGERY | SCIE | Q3 | — | 126/199 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 50/68 |
| 2010 | SURGERY | SCIE | Q2 | — | 87/188 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 46/61 |
| 2009 | SURGERY | SCIE | Q3 | — | 90/167 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 44/56 |
| 2008 | SURGERY | SCIE | Q3 | — | 83/148 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/54 |
| 2007 | SURGERY | SCIE | Q2 | — | 55/139 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 35/52 |
| 2006 | SURGERY | SCIE | Q2 | — | 59/137 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 36/51 |
| 2005 | SURGERY | SCIE | Q2 | — | 57/139 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 37/51 |
| 2004 | SURGERY | SCIE | Q2 | — | 67/139 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 37/52 |
| 2003 | SURGERY | SCIE | Q3 | — | 71/141 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 40/52 |
| 2002 | SURGERY | SCIE | Q2 | — | 70/141 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/50 |
| 2001 | SURGERY | SCIE | Q2 | — | 55/139 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 29/45 |
| 2000 | SURGERY | SCIE | Q2 | — | 52/136 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 29/44 |
| 1999 | SURGERY | SCIE | Q2 | — | 48/131 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 23/39 |
| 1998 | SURGERY | SCIE | Q2 | — | 52/128 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 34/62 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 24/38 |
| 1997 | SURGERY | SCIE | Q3 | — | 58/114 |